INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 58 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,621 | -53.8% | 29,948 | 0.0% | 0.00% | – |
| Q3 2022 | $36,000 | +89.5% | 29,948 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -92.9% | 29,948 | -87.3% | 0.00% | – |
| Q1 2022 | $269,000 | -44.5% | 235,240 | +9.2% | 0.00% | – |
| Q4 2021 | $485,000 | -34.2% | 215,450 | 0.0% | 0.00% | – |
| Q3 2021 | $737,000 | +14.3% | 215,450 | -0.1% | 0.00% | – |
| Q2 2021 | $645,000 | +564.9% | 215,572 | +619.8% | 0.00% | – |
| Q1 2021 | $97,000 | +51.6% | 29,948 | 0.0% | 0.00% | – |
| Q4 2020 | $64,000 | +77.8% | 29,948 | 0.0% | 0.00% | – |
| Q3 2020 | $36,000 | +28.6% | 29,948 | 0.0% | 0.00% | – |
| Q2 2020 | $28,000 | +7.7% | 29,948 | 0.0% | 0.00% | – |
| Q1 2020 | $26,000 | -10.3% | 29,948 | 0.0% | 0.00% | – |
| Q4 2019 | $29,000 | -6.5% | 29,948 | 0.0% | 0.00% | – |
| Q3 2019 | $31,000 | -42.6% | 29,948 | 0.0% | 0.00% | – |
| Q2 2019 | $54,000 | -5.3% | 29,948 | 0.0% | 0.00% | – |
| Q1 2019 | $57,000 | -74.0% | 29,948 | -55.6% | 0.00% | – |
| Q1 2017 | $219,000 | +138.0% | 67,500 | 0.0% | 0.00% | – |
| Q4 2016 | $92,000 | -13.2% | 67,500 | 0.0% | 0.00% | – |
| Q3 2016 | $106,000 | -8.6% | 67,500 | -22.5% | 0.00% | – |
| Q2 2016 | $116,000 | -85.6% | 87,100 | -42.9% | 0.00% | -100.0% |
| Q1 2016 | $804,000 | -32.0% | 152,493 | +1.3% | 0.00% | -50.0% |
| Q4 2015 | $1,183,000 | -76.7% | 150,590 | -74.9% | 0.00% | -71.4% |
| Q3 2015 | $5,079,000 | -17.9% | 601,022 | +6.4% | 0.01% | -22.2% |
| Q2 2015 | $6,183,000 | -46.5% | 564,657 | -31.7% | 0.01% | -43.8% |
| Q1 2015 | $11,551,000 | +81.1% | 826,210 | +118.7% | 0.02% | +60.0% |
| Q4 2014 | $6,380,000 | +294.1% | 377,712 | +213.2% | 0.01% | +233.3% |
| Q3 2014 | $1,619,000 | +1.3% | 120,589 | -3.9% | 0.00% | 0.0% |
| Q2 2014 | $1,599,000 | +6.5% | 125,482 | -0.6% | 0.00% | 0.0% |
| Q1 2014 | $1,502,000 | -18.1% | 126,266 | -4.9% | 0.00% | 0.0% |
| Q4 2013 | $1,834,000 | -10.7% | 132,761 | +10.5% | 0.00% | -25.0% |
| Q3 2013 | $2,054,000 | +21.1% | 120,164 | +17.5% | 0.00% | 0.0% |
| Q2 2013 | $1,696,000 | – | 102,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |